KAI Pharmaceuticals Director of Finance Salary | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals Director of Finance Salary

The average KAI Pharmaceuticals Director of Finance earns an estimated $165,684 annually. KAI Pharmaceuticals' Director of Finance compensation is $3,668 more than the US average for a Director of Finance.

The Finance Department at KAI Pharmaceuticals earns $4,984 more on average than the Customer Support Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$165,684
Average Compensation
$165,684
avg. base

Director of Finance Salaries at KAI Pharmaceuticals

Directors of Finance earn $26,607 more than Accounting Managers.

Accounting Manager
$139k*
Business Analyst
$118k*
Financial Analyst
$114k*
Senior Accountant
$109k*
Accountant
$85k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

The Finance Department averages $4,984 more than the Customer Support Department, and $129 less than the Operations Department

Operations
$103,725 Avg. total comp.
+$129
Finance
$103,596 Avg. total comp.
Customer Support
$98,612 Avg. total comp.
-$5k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to KAI Pharmaceuticals reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to KAI Pharmaceuticals reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at KAI Pharmaceuticals Rate Their Compensation

The majority of Directors of Finance at KAI Pharmaceuticals believe they're compensated fairly. 100% of Directors of Finance at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company